Multiple Rising Oral Doses of BI 1060469 in Healthy and Mild Asthma Subjects

Condition:   Asthma
Interventions:   Drug: Placebo to BI 1060469;   Drug: BI 1060469 Healthy;   Drug: Placebo to BI 1060469 asthmatics;   Drug: BI 1060469 asthmatics
Sponsor:   Boehringer Ingelheim
Not yet recruiting – verified April 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days